{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:39:37Z","timestamp":1790048377452,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3968,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/labinvest.2011.191","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T08:44:01Z","timestamp":1324284241000},"page":"384-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis"],"prefix":"10.1016","volume":"92","author":[{"given":"Ferdinando A","family":"Giannone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Baldassarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Domenicali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Zaccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2011.191_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2011.191_bib2","doi-asserted-by":"crossref","first-page":"G357","DOI":"10.1152\/ajpgi.00456.2007","article-title":"Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis","volume":"294","author":"Siegmund","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.2011.191_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.20733","article-title":"Daily cannabis smoking as a risk factor for fibrosis progression in chronic hepatitis C","volume":"42","author":"H\u00e9zode","year":"2005","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.191_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2011.191_bib5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","article-title":"Antifibrogenic role of the cannabinoid receptor CB2 in the liver","volume":"128","author":"Julien","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.191_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beem.2008.10.013","article-title":"An introduction to the endocannabinoid system: from the early to the latest concepts","volume":"23","author":"De Petrocellis","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.2011.191_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.beem.2008.10.009","article-title":"The role of the endocannabinoid system in liver diseases","volume":"23","author":"Caraceni","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.2011.191_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2009.01.004","article-title":"Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis","volume":"137","author":"Domenicali","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.191_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2005.01.034","article-title":"A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis","volume":"43","author":"Domenicali","year":"2005","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.2011.191_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1038\/labinvest.2011.191_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pharmthera.2010.10.006","article-title":"Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas","volume":"129","author":"Li","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1038\/labinvest.2011.191_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","article-title":"A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues","volume":"112","author":"Jamall","year":"1981","journal-title":"Anal Biochem"},{"key":"10.1038\/labinvest.2011.191_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/gut.2007.147652","article-title":"Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia","volume":"58","author":"Caraceni","year":"2009","journal-title":"Gut"},{"key":"10.1038\/labinvest.2011.191_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Schmittgen. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method","volume":"25","author":"Kenneth","year":"2001","journal-title":"Methods"},{"key":"10.1038\/labinvest.2011.191_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02706220","article-title":"Role of matrix metalloprotease-2 in oxidant activation of Ca2 ATPase by hydrogen peroxide in pulmonary vascular smooth muscle plasma membrane","volume":"28","author":"Mandal","year":"2003","journal-title":"J Biosci"},{"key":"10.1038\/labinvest.2011.191_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2011.191_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1038\/labinvest.2011.191_bib18","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1096\/fj.06-7717com","article-title":"The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species","volume":"21","author":"Siegmund","year":"2007","journal-title":"FASEB J"},{"key":"10.1038\/labinvest.2011.191_bib19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hep.20667","article-title":"Anandamide induces necrosis in primary hepatic stellate cells","volume":"41","author":"Siegmund","year":"2005","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.191_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9440(10)65299-6","article-title":"Oval cell numbers in human chronic liver diseases are directly related to disease severity","volume":"154","author":"Lowes","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2011.191_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2007.05.012","article-title":"Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction","volume":"133","author":"Richardson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.191_bib22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/gast.1996.v110.pm8566602","article-title":"Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells","volume":"110","author":"Pinzani","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.191_bib23","doi-asserted-by":"crossref","first-page":"G27","DOI":"10.1152\/ajpgi.90405.2008","article-title":"Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease","volume":"297","author":"Feng","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.2011.191_bib24","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/hep.22278","article-title":"Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration","volume":"47","author":"Aram","year":"2008","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.191_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy - review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1038\/labinvest.2011.191_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.0904484","article-title":"New insights into the molecular mechanism of interleukin-10-mediated immunosuppression","volume":"77","author":"Gr\u00fctz","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1038\/labinvest.2011.191_bib27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/hep.510280621","article-title":"Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice","volume":"28","author":"Louis","year":"1998","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.191_bib28","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3748\/wjg.v10.i17.2574","article-title":"Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells","volume":"10","author":"Zhang","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1038\/labinvest.2011.191_bib29","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3748\/wjg.v12.i12.1918","article-title":"Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver","volume":"12","author":"Zhang","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1038\/labinvest.2011.191_bib30","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.molimm.2006.11.025","article-title":"Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease","volume":"44","author":"O'Sullivan","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1038\/labinvest.2011.191_bib31","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2741\/3886","article-title":"JAK-STAT signaling in hepatic fibrosis","volume":"17","author":"Mair","year":"2011","journal-title":"Front Biosci"},{"key":"10.1038\/labinvest.2011.191_bib32","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/sj.onc.1209281","article-title":"Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production","volume":"25","author":"Ogata","year":"2006","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.2011.191_bib33","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1038\/sj.onc.1208788","article-title":"Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK\/STAT and FAK signalings in human hepatocellular carcinoma","volume":"24","author":"Niwa","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/labinvest.2011.191_bib34","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"Arthur","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.2011.191_bib35","first-page":"176","article-title":"Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis","volume":"24","author":"Iredale","year":"1996","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.191_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","article-title":"Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver","volume":"110","author":"Benyon","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2011.191_bib37","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1478-3231.2004.0946.x","article-title":"Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis","volume":"24","author":"Zhou","year":"2004","journal-title":"Liver Int"},{"key":"10.1038\/labinvest.2011.191_bib38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1440-1746.2008.05756.x","volume":"24","author":"Luo","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1038\/labinvest.2011.191_bib39","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.3748\/wjg.v10.i24.3621","article-title":"Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats","volume":"10","author":"Xu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1038\/labinvest.2011.191_bib40","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2010.09.026","article-title":"The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension","volume":"54","author":"Lin","year":"2011","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.2011.191_bib41","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1074\/jbc.M111490200","article-title":"Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis","volume":"277","author":"Murphy","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2011.191_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","article-title":"Therapeutic strategies against TGF-beta signalling pathway in hepatic fibrosis","volume":"26","author":"Liu","year":"2006","journal-title":"Liver Int"},{"key":"10.1038\/labinvest.2011.191_bib43","first-page":"583","article-title":"The anti-fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile duct-ligated rats","volume":"23","author":"D\u00edaz-Gil","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1038\/labinvest.2011.191_bib44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2009.02137.x","article-title":"Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis","volume":"30","author":"Caraceni","year":"2010","journal-title":"Liver Int"},{"key":"10.1038\/labinvest.2011.191_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.107.131896","article-title":"Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats","volume":"324","author":"Munoz-Luque","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/labinvest.2011.191_bib46","doi-asserted-by":"crossref","DOI":"10.2119\/molmed.2011.00149","article-title":"Cannabinoid receptor type I modulates alcohol-induced liver fibrosis.","author":"Patsenker","year":"2011","journal-title":"Mol Med"},{"key":"10.1038\/labinvest.2011.191_bib47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1478-3231.2011.02496.x","article-title":"Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts","volume":"31","author":"Trebicka","year":"2011","journal-title":"Liver Int"},{"key":"10.1038\/labinvest.2011.191_bib48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.24077","article-title":"Endocannabinoids in liver disease","volume":"53","author":"Tam","year":"2011","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2011.191_bib49","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J Clin Invest"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2011191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2011191","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372202699X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002368372202699X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2011191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:51:23Z","timestamp":1758397883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002368372202699X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S002368372202699X"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2011.191","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2011.191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}